-
A5391: Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide
Weight gain after starting HIV therapy is common, but recent studies have found that some people with HIV (PWH) who…
Closed to accrual
HIV comorbidities and complications
Participants will be on study treatment for 48 weeks.
-
Since the early days of the HIV epidemic cytomegalovirus (CMV) has been one of the most common and devastating opportunistic…
Closed to accrual
HIV comorbidities and complications
About 2 years (96 weeks).
-
This study will include 180 participants. Participants will have HIV and Cytomegalovirus (CMV). CMV is common virus that many people…
Closed to accrual
HIV comorbidities and complications